Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Maxillary sinusitis is characterized by facial pain and pressure in the cheek area that worsens with bending over or lying ...

HealthDay News — Psilocybin-assisted therapy (PAT) shows long-term safety and efficacy for treating symptoms of major depressive disorder (MDD), according to a study published in the Journal of ...

North Carolina and Idaho are cutting their Medicaid programs to bridge budget gaps, raising fears that providers will stop ...

HealthDay News — During August 2021 to August 2023, only 36.4% of US adults had no cardiovascular disease (CVD) risk factors, according to a September data brief published by the National Center for ...

Researchers explored the impact of polypharmacy on long-term treatment response among patients with early rheumatoid arthritis.

HealthDay News — The US Food and Drug Administration (FDA) has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ...

Utah has reported 27 cases so far; Arizona has 42 confirmed cases, including 1 child who has been hospitalized.

Helen Tager-Flusberg, director of the Center for Autism Research Excellence at Boston University, called Trump’s comments dangerous. Fevers can harm the mother and the developing fetus, she said, ...